欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0243/002
药品名称Cazitel Plus XL Tablets
活性成分
    • febantel 525.0 mg
    • praziquantel 175.0 mg
    • pyrantel embonate 504.0 mg
剂型Tablet
上市许可持有人Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea Co. Galway Ireland
参考成员国 - 产品名称Ireland (IE)
Cazitel Plus XL Tablets for Dogs
互认成员国 - 产品名称
    • Germany (DE)
      Cazitel Plus XL Tablets
    • Belgium (BE)
      Frontcontrol Wormer XL
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
      Cazitel Plus XL Tablets
    • Austria (AT)
    • Spain (ES)
      Cazitel Comprimidos para perros Grandes
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Cazitel Plus XL
    • Lithuania (LT)
    • Estonia (EE)
      Cazitel Plus XL
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • France (FR)
许可日期2012/06/27
最近更新日期2024/01/04
药物ATC编码
    • QP52AF02 pyrantel
    • QP52AC05 febantel
    • QP52AA01 praziquantel
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase